# GENETIC VARIABILITY TO GLP1 TREATMENT

> **NCT06298799** · NA · UNKNOWN · sponsor: **GENGE** · enrollment: 400 (estimated)

## Conditions studied

- Type 2 Diabetes
- Obesity

## Interventions

- **GENETIC:** DNA Sequencing and Analysis
- **GENETIC:** differential expression analysis with RNA-sequencing (RNA seq) experiments

## Key facts

- **NCT ID:** NCT06298799
- **Lead sponsor:** GENGE
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06298799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06298799, "GENETIC VARIABILITY TO GLP1 TREATMENT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06298799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*